Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1Phase 2 1

Status

Recruiting 1Not yet recruiting 1Completed 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Myeloid 3Classical hematology 1

Conditions

Colorectal Neoplasms 8Venous Thromboembolism 4Polycythemia Vera 3Prostatic Neoplasms 2Neoplasms 2Myeloproliferative Disorders 2Fallopian Tube Neoplasms 2Colorectal Neoplasms, Hereditary Nonpolyposis 2Breast Neoplasms 2Thrombocythemia, Essential 1Testicular Neoplasms 1Smoking Cessation 1Sarcoma 1Primary Myelofibrosis 1Ovarian Neoplasms 1Ovarian Cancer Prevention 1Neuroma, Acoustic 1Neurofibromatosis 2 1Neoplasms, Germ Cell and Embryonal 1Multiple Myeloma 1Motor Activity 1Lung Neoplasms 1Liver Cirrhosis 1Leukemia, Hairy Cell 1Inflammation 1Hemorrhage 1Hematoma 1Fibrosis 1Endometrial Neoplasms 1Colorectal Neoplasia 1

Interventions

ruxolitinib 10fludarabine phosphate 5Whole-Body Irradiation 5Cyclophosphamide 5Tacrolimus 4Peripheral Blood Stem Cell Transplantation 4Mycophenolic Acid 4Hydroxyurea 4bomedemstat 3Stem Cell Transplantation 3Specimen Handling 3Busulfan 3Biopsy 3Aspirin 3fludarabine 2Phlebotomy 2Methotrexate 2Melphalan 2Injections 2Azacitidine 2venetoclax 1veliparib 1umbralisib 1piperine 1pevonedistat 1methanesulfonic acid 1itacitinib 1iadademstat 1givinostat hydrochloride 1givinostat 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Polycythemia Vera × Aspirin × 1 year × Clear all
NCT05198960 2026-03-20

AVAJAK

University Hospital, Brest

Phase 3 Recruiting
1,308 enrolled
Classical hematologyMyeloid

Hemorrhage, Polycythemia Vera, Thrombocythemia, Essential, Venous Thromboembolism, Primary Myelofibrosis

NCT04182100 2025-09-15

Efficacy and Safety of P1101 in Polycythemia Vera Patients for Whom the Standard of Treatment is Difficult to Apply

PharmaEssentia Japan K.K.

Phase 2 Completed
29 enrolled 15 charts
Myeloid

Myeloproliferative Disorders, Polycythemia Vera

NCT06290765 2025-07-31

PV

PharmaEssentia

Phase 4 Not yet recruiting
70 enrolled
Myeloid

Myeloproliferative Disorders, Polycythemia Vera

Data powered by HemOnc (CC BY 4.0) Colophon âš¡